Toshio Takagi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 60

Top Topics

Combination Therapy

Kidney Transplantation

Editorial Comment

Top Venues

International journal of urology : official journal of the Japanese Urological Association

Japanese journal of clinical oncology

IJU case reports

Geriatrics & gerontology international

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroki Ishihara, Toshio Takagi
Editorial Comment on Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Toshio Takagi, Kenji Omae, Kazuhiko Yoshida, Hironori Fukuda, Yuki Kobari, Hiroki Ishihara, Junpei Iizuka, Tsunenori Kondo, Hideki Ishida
Comparisons of survival and surgical outcomes between minimally invasive partial nephrectomy and radical nephrectomy in elderly patients with stage 1 renal cell carcinoma. Geriatrics & gerontology international (2024)
Ryoichi Maenosono, Kohei Unagami, Rikako Oki, Yuya Fujiwara, Taro Banno, Daigo Okada, Takafumi Yagisawa, Taichi Kanzawa, Toshihito Hirai, Kazuya Omoto, Norio Hanafusa, Haruhito Azuma, Toshio Takagi, Hideki Ishida
The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks. International journal of urology : official journal of the Japanese Urological Association (2024)
Toshio Takagi, Kazuhiko Yoshida, Hironori Fukuda, Yuki Kobari, Hiroki Ishihara, Junpei Iizuka
Comparison of surgical outcomes of robot-assisted laparoscopic partial nephrectomy performed by a single experienced surgeon according to two reconstruction methods, including single-layer and double-layer renorrhaphy. Journal of robotic surgery 18 (1) (2024)
Ryoichi Maenosono, Kohei Unagami, Rikako Oki, Yuya Fujiwara, Taro Banno, Daigo Okada, Takafumi Yagisawa, Taichi Kanzawa, Toshihito Hirai, Kazuya Omoto, Norio Hanafusa, Haruhito Azuma, Toshio Takagi, Hideki Ishida
The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2024)
Hiroki Ishihara, Nemoto Yuki, Ryo Ishiyama, Takashi Ikeda, Yuki Kobari, Hironori Fukuda, Kazuhiko Yoshida, Hiroaki Shimmura, Yasunobu Hashimoto, Junpei Iizuka, Tsunenori Kondo, Toshio Takagi
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up. Japanese journal of clinical oncology (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment to The DDD score outperforms the RENAL score in predicting high-grade renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Toshio Takagi, Kenji Omae, Kazuhiko Yoshida, Hironori Fukuda, Yuki Kobari, Hiroki Ishihara, Junpei Iizuka, Tsunenori Kondo, Hideki Ishida
Comparisons of survival and surgical outcomes between minimally invasive partial nephrectomy and radical nephrectomy in elderly patients with stage 1 renal cell carcinoma. Geriatrics & gerontology international 24 (3) (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International journal of urology : official journal of the Japanese Urological Association (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Toshio Takagi, Kenji Omae, Kazuhiko Yoshida, Hironori Fukuda, Yuki Kobari, Hiroki Ishihara, Junpei Iizuka, Tsunenori Kondo, Hideki Ishida
Comparisons of survival and surgical outcomes between minimally invasive partial nephrectomy and radical nephrectomy in elderly patients with stage 1 renal cell carcinoma. Geriatrics & gerontology international 24 (3) (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment to The DDD score outperforms the RENAL score in predicting high-grade renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Hiroki Ishihara, Nemoto Yuki, Ryo Ishiyama, Takashi Ikeda, Yuki Kobari, Hironori Fukuda, Kazuhiko Yoshida, Hiroaki Shimmura, Yasunobu Hashimoto, Junpei Iizuka, Tsunenori Kondo, Toshio Takagi
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up. Japanese journal of clinical oncology 54 (5) (2024)
Takafumi Yagisawa, Toshio Takagi
Editorial Comment on "Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan". International journal of urology : official journal of the Japanese Urological Association (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association (2024)
Ryoichi Maenosono, Kohei Unagami, Rikako Oki, Yuya Fujiwara, Taro Banno, Daigo Okada, Takafumi Yagisawa, Taichi Kanzawa, Toshihito Hirai, Kazuya Omoto, Norio Hanafusa, Haruhito Azuma, Toshio Takagi, Hideki Ishida
The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment to The DDD score outperforms the RENAL score in predicting high-grade renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Takafumi Yagisawa, Toshio Takagi
Editorial Comment on "Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan". International journal of urology : official journal of the Japanese Urological Association 31 (7) (2024)
Hiroki Ishihara, Nemoto Yuki, Ryo Ishiyama, Takashi Ikeda, Yuki Kobari, Hironori Fukuda, Kazuhiko Yoshida, Hiroaki Shimmura, Yasunobu Hashimoto, Junpei Iizuka, Tsunenori Kondo, Toshio Takagi
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up. Japanese journal of clinical oncology 54 (5) (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Takafumi Yagisawa, Toshio Takagi
Editorial Comment on "Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan". International journal of urology : official journal of the Japanese Urological Association 31 (7) (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment to The DDD score outperforms the RENAL score in predicting high-grade renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association (2024)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Hiroki Ishihara, Nemoto Yuki, Ryo Ishiyama, Takashi Ikeda, Yuki Kobari, Hironori Fukuda, Kazuhiko Yoshida, Hiroaki Shimmura, Yasunobu Hashimoto, Junpei Iizuka, Tsunenori Kondo, Toshio Takagi
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up. Japanese journal of clinical oncology 54 (5) (2024)
Masayoshi Okumi, Kazuya Omoto, Tomokazu Shimizu, Hiroki Shirakawa, Kohei Unagami, Takumi Lee, Hideki Ishida, Kazunari Tanabe, Toshio Takagi
Long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation: The Japan Academic Consortium of Kidney Transplantation study-II. International journal of urology : official journal of the Japanese Urological Association (2023)
Takafumi Yagisawa, Taichi Kanzawa, Toshihito Hirai, Kohei Unagami, Yoko Shirai, Kiyonobu Ishizuka, Kenichiro Miura, Motoshi Hattori, Hideki Ishida, Toshio Takagi
En bloc kidney transplantation from pediatric donors to teenage recipients: Two case reports. IJU case reports 7 (2) (2023)
Kazuhiko Yoshida, Nao Oida, Tsunenori Kondo, Yuki Kobari, Hiroki Ishihara, Hironori Fukuda, Junpei Iizuka, Hirohito Kobayashi, Hideki Ishida, Toshio Takagi
Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results-Medicare data. International journal of urology : official journal of the Japanese Urological Association 30 (3) (2023)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results-Medicare data. International journal of urology : official journal of the Japanese Urological Association (2023)
Hiroki Ishihara, Takashi Ikeda, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Yoji Nagashima, Tsunenori Kondo, Toshio Takagi
Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions. International journal of urology : official journal of the Japanese Urological Association (2023)
Hiroaki Shimmura, Taro Banno, Kazutaka Nakamura, Anju Murayama, Haruki Shigeta, Toyoaki Sawano, Yukiko Kouchi, Akihhiko Ozaki, Fumito Yamabe, Junpei Iizuka, Toshio Takagi
A single-center retrospective comparative analysis of urinary continence in robotic prostatectomy with a combination of umbilical ligament preservation and Hood technique. International journal of urology : official journal of the Japanese Urological Association (2023)
Hiroki Ishihara, Yuki Nemoto, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Yasunobu Hashimoto, Tsunenori Kondo, Toshio Takagi
Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma. Japanese journal of clinical oncology (2023)
Takafumi Yagisawa, Taichi Kanzawa, Toshihito Hirai, Kohei Unagami, Yoko Shirai, Kiyonobu Ishizuka, Kenichiro Miura, Motoshi Hattori, Hideki Ishida, Toshio Takagi
En bloc kidney transplantation from pediatric donors to teenage recipients: Two case reports. IJU case reports 7 (2) (2023)
Kazuhiko Yoshida, Nao Oida, Tsunenori Kondo, Yuki Kobari, Hiroki Ishihara, Hironori Fukuda, Junpei Iizuka, Hirohito Kobayashi, Hideki Ishida, Toshio Takagi
Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Kazuhiko Yoshida, Nao Oida, Tsunenori Kondo, Yuki Kobari, Hiroki Ishihara, Hironori Fukuda, Junpei Iizuka, Hirohito Kobayashi, Hideki Ishida, Toshio Takagi
Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy. International journal of urology : official journal of the Japanese Urological Association (2023)
Hiroki Ishihara, Toshio Takagi
Editorial Comment on Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results-Medicare data. International journal of urology : official journal of the Japanese Urological Association 30 (3) (2023)
Sekiko Taneda, Kazuho Honda, Junki Koike, Naoko Ito, Hideki Ishida, Toshio Takagi, Yoji Nagashima
Clinicopathological differences in focal segmental glomerulosclerosis depending on the accompanying pathophysiological conditions in renal allografts. Virchows Archiv : an international journal of pathology (2023)
Hiroki Ishihara, Toshio Takagi
Editorial Comment to Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study. International journal of urology : official journal of the Japanese Urological Association (2023)
Arisa Wada, Kenji Omae, Kazuhiko Yoshida, Tsunenori Kondo, Kazunari Tanabe, Toshio Takagi
Comparison of surgical outcomes after robot-assisted laparoscopic partial nephrectomy between patients continuing and discontinuing aspirin therapy: a Japanese single-centre study. Japanese journal of clinical oncology 52 (5) (2022)
Hiroki Ishihara, Yuki Nemoto, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Yasunobu Hashimoto, Toshio Takagi, Hideki Ishida, Tsunenori Kondo, Kazunari Tanabe
Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up. Japanese journal of clinical oncology 52 (7) (2022)
Hiroki Ishihara, Hironori Fukuda, Kazuhiko Yoshida, Yasunobu Hashimoto, Tsunenori Kondo, Toshio Takagi
Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association (2022)
Makoto Toguchi, Tsunenori Kondo, Kazuhiko Yoshida, Kazunari Tanabe, Toshio Takagi
Perioperative outcomes following robot-assisted partial nephrectomy for renal cell carcinoma according to surgeon generation. BMC surgery 22 (1) (2022)
Kazuhiko Yoshida, Yuki Kobari, Junpei Iizuka, Tsunenori Kondo, Hideki Ishida, Kazunari Tanabe, Toshio Takagi
Robot-assisted laparoscopic versus open partial nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease. International journal of urology : official journal of the Japanese Urological Association 29 (11) (2022)
Hiroki Ishihara, Tsunenori Kondo, Toshio Takagi
Editorial Comment from Dr Ishihara et al. to Nomogram for predicting survival of renal cell carcinoma with tumor thrombus based on perioperative clinicopathological factors from a Chinese high-volume center. International journal of urology : official journal of the Japanese Urological Association 29 (9) (2022)
Maki Yoshino, Hiroki Ishihara, Yuki Nemoto, Kazutaka Nakamura, Koichi Nishimura, Hidekazu Tachibana, Hironori Fukuda, Daisuke Toki, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Kazunari Tanabe, Tsunenori Kondo, Toshio Takagi
Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab. Japanese journal of clinical oncology 52 (10) (2022)
Yudai Ishiyama, Tsunenori Kondo, Kazuhiko Yoshida, Junpei Iizuka, Kazunari Tanabe, Toshio Takagi
"Thrombus-first" or "thrombus-last" approach for surgical management of renal cell carcinoma with inferior vena cava thrombus. International journal of urology : official journal of the Japanese Urological Association 29 (6) (2022)
Toshio Takagi
Optimization of first-line systemic therapy in patients with advanced clear cell renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association (2022)
Toshio Takagi, Kazuhiko Yoshida, Hironori Fukuda, Yuki Kobari, Junpei Iizuka
Analyses of operative time according to procedure phases during robot-assisted laparoscopic partial nephrectomy using the iPhone application "My Intuitives". International journal of urology : official journal of the Japanese Urological Association 29 (11) (2022)
Takafumi Yagisawa, Toshio Takagi, Kazuhiko Yoshida, Keisuke Hata, Junpei Iizuka, Yasuto Muromiya, Tsunenori Kondo, Kazunari Tanabe
Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma. Journal of robotic surgery (2021)
Yu Kijima, Tomokazu Shimizu, Shinya Kato, Eri Sekido, Kana Kano, Makoto Toguchi, Toshihide Horiuchi, Hiroshi Toma, Shoichi Iida, Toshio Takagi
A case of novel coronavirus disease after combination therapy with nivolumab and ipilimumab for metastatic renal cell carcinoma. IJU case reports 5 (2) (2021)
Yudai Ishiyama, Tsunenori Kondo, Hiroki Ishihara, Kazuhiko Yoshida, Junpei Iizuka, Kazunari Tanabe, Toshio Takagi
Association between Ureteral Clamping Time and Acute Kidney Injury during Robot-Assisted Radical Cystectomy. Current oncology (Toronto, Ont.) 28 (6) (2021)
Hiroki Ishihara, Tsunenori Kondo, Kazutaka Nakamura, Yuki Nemoto, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Kazunari Tanabe, Toshio Takagi
Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma. Japanese journal of clinical oncology 51 (12) (2021)
Toshio Takagi
Editorial Comment to Successful recovery from coronavirus disease 2019 in a living kidney transplant recipient using low-dose methylprednisolone. IJU case reports 4 (1) (2020)
Toshio Takagi, Hironori Fukuda, Tsunenori Kondo, Hiroki Ishihara, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Masayoshi Okumi, Hideki Ishida, Kazunari Tanabe
Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy. Targeted oncology 14 (2) (2020)
Toshio Takagi, Kazuhiko Yoshida, Tsunenori Kondo, Hirohito Kobayashi, Junpei Iizuka, Masayoshi Okumi, Hideki Ishida, Kazunari Tanabe
Comparisons of surgical outcomes between transperitoneal and retroperitoneal approaches in robot-assisted laparoscopic partial nephrectomy for lateral renal tumors: a propensity score-matched comparative analysis. Journal of robotic surgery 15 (1) (2020)
Toshio Takagi, Kazuhiko Yoshida, Arisa Wada, Tsunenori Kondo, Hironori Fukuda, Hiroki Ishihara, Hirohito Kobayashi, Junpei Iizuka, Masayoshi Okumi, Hideki Ishida, Yoji Nagashima, Kazunari Tanabe
Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution. International journal of clinical oncology 25 (5) (2020)
Yudai Ishiyama, Toshio Takagi, Kazuhiko Yoshida, Junpei Iizuka, Yoichi Kakuta, Masayoshi Okumi, Hideki Ishida, Kazunari Tanabe
Possible abscopal effect in urothelial carcinoma of the upper urinary tract after treatment with immune checkpoint inhibitors. IJU case reports 3 (1) (2019)